Summit Financial Group, Inc. Pfizer Inc Transaction History

Summit Financial Group, Inc.

$279 Million
Q1 2024

A detailed history of Summit Financial Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Summit Financial Group, Inc. holds 31,902 shares of PFE stock, worth $837,108. This represents 0.32% of its overall portfolio holdings.

Number of Shares

31,902

Previous 32,252 1.09%

Holding current value

$837,108

Previous $928,000 4.63%

% of portfolio

0.32%

Previous 0.36%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$25.89 - $29.73 $9,061 - $10,405	-350 Reduced 1.09%	31,902 $885,000
Q4 2023 Jan 12, 2024	BUY	$26.13 - $33.94 $3,658 - $4,751	140 Added 0.44%	32,252 $928,000
Q3 2023 Oct 17, 2023	SELL	$32.09 - $37.51 $75,732 - $88,523	-2,360 Reduced 6.85%	32,112 $1.07 Million
Q2 2023 Jul 13, 2023	SELL	$36.12 - $41.79 $67,002 - $77,520	-1,855 Reduced 5.11%	34,472 $1.26 Million
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $11,580 - $15,076	-294 Reduced 0.8%	36,327 $1.48 Million
Q4 2022 Jan 09, 2023	SELL	$41.75 - $54.5 $44,547 - $58,151	-1,067 Reduced 2.83%	36,621 $1.88 Million
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $20,129 - $24,573	-460 Reduced 1.21%	37,688 $1.65 Million
Q2 2022 Jul 07, 2022	SELL	$46.53 - $55.17 $6,979 - $8,275	-150 Reduced 0.39%	38,148 $2 Million
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $134,962 - $167,235	2,950 Added 8.35%	38,298 $1.98 Million
Q4 2021 Jan 10, 2022	BUY	$41.32 - $61.25 $30,163 - $44,712	730 Added 2.11%	35,348 $2.09 Million
Q2 2021 Jul 06, 2021	BUY	$35.91 - $40.68 $8,977 - $10,170	250 Added 0.73%	34,618 $1.36 Million
Q1 2021 Apr 07, 2021	SELL	$33.49 - $37.77 $7,535 - $8,498	-225 Reduced 0.65%	34,368 $1.25 Million
Q4 2020 Jan 07, 2021	SELL	$33.47 - $42.56 $8,367 - $10,640	-250 Reduced 0.72%	34,593 $1.27 Million
Q2 2020 Jul 06, 2020	BUY	$30.12 - $36.54 $50,541 - $61,314	1,678 Added 5.06%	34,843 $1.14 Million
Q1 2020 Apr 03, 2020	SELL	$27.03 - $38.62 $1,135 - $1,622	-42 Reduced 0.13%	33,165 $1.08 Million
Q4 2019 Jan 06, 2020	SELL	$32.92 - $37.36 $20,904 - $23,723	-635 Reduced 1.88%	33,207 $1.3 Million
Q3 2019 Oct 09, 2019	SELL	$32.49 - $42.13 $143,670 - $186,298	-4,422 Reduced 11.56%	33,842 $1.22 Million
Q2 2019 Jul 03, 2019	SELL	$36.98 - $41.52 $222,175 - $249,452	-6,008 Reduced 13.57%	38,264 $1.66 Million
Q3 2018 Oct 03, 2018	SELL	$34.47 - $41.81 $1,654 - $2,006	-48 Reduced 0.11%	44,272 $1.95 Million
Q1 2018 Apr 04, 2018	BUY	$31.91 - $37.02 $57,438 - $66,636	1,800 Added 4.23%	44,320 $1.57 Million
Q4 2017 Jan 04, 2018	SELL	$33.26 - $35.29 $49,890 - $52,935	-1,500 Reduced 3.41%	42,520 $1.54 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $1.36 Million - $1.5 Million	44,020	44,020 $1.57 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.

Account

Summit Financial Group, Inc. Pfizer Inc Transaction History